These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 17536105)

  • 1. Beyond detection: novel applications for PET imaging to guide cancer therapy.
    Rajendran JG; Mankoff DA
    J Nucl Med; 2007 Jun; 48(6):855-6. PubMed ID: 17536105
    [No Abstract]   [Full Text] [Related]  

  • 2. Pretreatment 18F-FAZA PET predicts success of hypoxia-directed radiochemotherapy using tirapazamine.
    Beck R; Röper B; Carlsen JM; Huisman MC; Lebschi JA; Andratschke N; Picchio M; Souvatzoglou M; Machulla HJ; Piert M
    J Nucl Med; 2007 Jun; 48(6):973-80. PubMed ID: 17536108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia in head and neck cancer: studies with hypoxic positron emission tomography imaging and hypoxic cytotoxins.
    Rischin D; Fisher R; Peters L; Corry J; Hicks R
    Int J Radiat Oncol Biol Phys; 2007; 69(2 Suppl):S61-3. PubMed ID: 17848298
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer.
    Grosu AL; Souvatzoglou M; Röper B; Dobritz M; Wiedenmann N; Jacob V; Wester HJ; Reischl G; Machulla HJ; Schwaiger M; Molls M; Piert M
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):541-51. PubMed ID: 17869667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accessing radiation response using hypoxia PET imaging and oxygen sensitive electrodes: a preclinical study.
    Mortensen LS; Busk M; Nordsmark M; Jakobsen S; Theil J; Overgaard J; Horsman MR
    Radiother Oncol; 2011 Jun; 99(3):418-23. PubMed ID: 21723634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia in head and neck cancer.
    Isa AY; Ward TH; West CM; Slevin NJ; Homer JJ
    Br J Radiol; 2006 Oct; 79(946):791-8. PubMed ID: 16854964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioreductive drugs in cancer therapy.
    Stratford IJ
    BJR Suppl; 1992; 24():128-36. PubMed ID: 1341908
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypoxia-imaging with (18)F-Misonidazole and PET: changes of kinetics during radiotherapy of head-and-neck cancer.
    Eschmann SM; Paulsen F; Bedeshem C; Machulla HJ; Hehr T; Bamberg M; Bares R
    Radiother Oncol; 2007 Jun; 83(3):406-10. PubMed ID: 17543402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioreductive therapy.
    Chaplin DJ
    Int J Radiat Oncol Biol Phys; 1992; 22(4):685-7. PubMed ID: 1544837
    [No Abstract]   [Full Text] [Related]  

  • 10. Targeting hypoxia in head and neck cancer.
    Peters LJ
    Acta Oncol; 2001; 40(8):937-40. PubMed ID: 11845958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin as a radiosensitizer in the treatment of locally advanced head and neck cancer.
    Altundag O; Altundag K; Morandi P; Hanrahan E
    Oral Oncol; 2005 Apr; 41(4):435. PubMed ID: 15792617
    [No Abstract]   [Full Text] [Related]  

  • 12. The response of a transplantable tumor to fractionated irradiation. 1. X rays and the hypoxic cell radiosensitizer Ro-07-0582.
    Denekamp J; Harris SR
    Radiat Res; 1976 Apr; 66(1):66-75. PubMed ID: 1257411
    [No Abstract]   [Full Text] [Related]  

  • 13. Identifying and targeting hypoxia in head and neck cancer: a brief overview of current approaches.
    Le QT
    Int J Radiat Oncol Biol Phys; 2007; 69(2 Suppl):S56-8. PubMed ID: 17848296
    [No Abstract]   [Full Text] [Related]  

  • 14. More lessons learned from the suffocation of hypoxia.
    Ang KK
    J Clin Oncol; 2010 Jun; 28(18):2941-3. PubMed ID: 20479396
    [No Abstract]   [Full Text] [Related]  

  • 15. Tests of two electron-affinic radiosensitizers in vivo using regrowth of an experimental carcinoma.
    Denekamp J; Harris SR
    Radiat Res; 1975 Feb; 61(2):191-203. PubMed ID: 1110975
    [No Abstract]   [Full Text] [Related]  

  • 16. The response of a transplantable tumor to fractionated irradiation. III. Fast neutrons plus the radiosensitizer Ro-07-0582.
    Denekamp J; Morris C; Field SB
    Radiat Res; 1977 May; 70(2):425-32. PubMed ID: 860014
    [No Abstract]   [Full Text] [Related]  

  • 17. Endogenous markers of tumor hypoxia predictors of clinical radiation resistance?
    Vordermark D; Brown JM
    Strahlenther Onkol; 2003 Dec; 179(12):801-11. PubMed ID: 14652668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of [18F]FETNIM: a potential marker for PET.
    Grönroos T; Eskola O; Lehtiö K; Minn H; Marjamäki P; Bergman J; Haaparanta M; Forsback S; Solin O
    J Nucl Med; 2001 Sep; 42(9):1397-404. PubMed ID: 11535732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining radiotherapy with systemic therapies.
    Vokes EE
    Clin Adv Hematol Oncol; 2008 Mar; 6(3):167-9. PubMed ID: 18391914
    [No Abstract]   [Full Text] [Related]  

  • 20. A model of reoxygenation dynamics of head-and-neck tumors based on serial 18F-fluoromisonidazole positron emission tomography investigations.
    Thorwarth D; Eschmann SM; Paulsen F; Alber M
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):515-21. PubMed ID: 17398015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.